You are here

Gemini Therapeutics

Gemini CEO out the door as 80% of staff laid off, strategic review gets underway

Fierce Biotech

Mon, 02/28/22 - 11:41 pm

Gemini Therapeutics

Gemini axes CSO and 20% of staff to focus on late-phase plans

Fierce Biotech

Tue, 10/5/21 - 10:43 am

Gemini Therapeutics

age-related macular degeneration

3 Biotech Stocks With Big Catalysts in June

Motley Fool

Tue, 06/22/21 - 10:55 am

Corbus Pharmaceuticals

clinical trials

Gemini Therapeutics

age-related macular degeneration

Intellia Therapeutics

Second-quarter catalysts for the smaller players

EP Vantage

Wed, 04/7/21 - 10:25 am

Fulcrum Therapeutics

Gemini Therapeutics

After Alexion buyout, ex-Achillion nephrology lead jumps ship to Gemini Therapeutics

Fierce Biotech

Fri, 05/8/20 - 10:21 am

Gemini Therapeutics